Showing results (161-170 of 452) with videos related to
Sort By:
Pageof 46
Current Radiopharmaceuticals|November 22, 2019
Ileal Melanoma, A Rare Cause of Small Bowel Obstruction: Report of a Case, and Short Literature ReviewEmanuele Sinagra, Carmelo SciumèCurrent Radiopharmaceuticals|December 21, 2019
PET/CT and the Response to Immunotherapy in Lung CancerLaura Evangelista, Matteo Sepulcri, Giulia PaselloCurrent Radiopharmaceuticals|March 19, 2020
The Multicenter Italian Trial Assesses the Performance of FDG-PET /CT Related to Pre-Test Cancer Risk in Patients with Solitary Pulmonary Nodules and Introduces a Segmental Thoracic Diagnostic StrategyMarco Spadafora, Laura Evangelista, Salvatore Fiordoro, et al.Current Radiopharmaceuticals|March 19, 2020
Radiotherapy Planning and Molecular Imaging in Lung CancerAngelina Filice, Massimiliano Casali, Patrizia Ciammella, et al.Current Radiopharmaceuticals|February 5, 2019
Peptide Receptor Radionuclide Therapy for Pancreatic Neuroendocrine TumoursShahad Alsadik, Siraj Yusuf, Adil Al-NahhasCurrent Radiopharmaceuticals|January 15, 2019
O-(2-[18F]-Fluoroethyl)-L-Tyrosine (FET) in Neurooncology: A Review of Experimental ResultsCarina Stegmayr, Antje Willuweit, Philipp Lohmann, et al.Current Radiopharmaceuticals|December 14, 2019
Evidence-Based Data About Prevalence and Risk of Malignancy of Thyroid Incidentalomas Detected by Different PET RadiopharmaceuticalsGiovanni Signore, Domenico Albano, Luca Giovanella, et al.Current Radiopharmaceuticals|May 12, 2025
[68Ga]Ga-DOTA-TOC Synthesis by a Cassette Developer System with [68Ga]GaCl3 from Cyclotron using Liquid Target: An Italian ExperienceMichela Cossandi, Massimo Statuto, Giorgio Biasiotto, et al.Current Radiopharmaceuticals|May 7, 2025
Real-world Data on Intermediate-risk Differentiated Thyroid Cancer Biochemical Response to 3700 or 5550 MBq of [131I]Sodium IodideDaniel M Machado, Daniel A Bulzico, Lídia F Fontes, et al.Pageof 46